Senescence and immortalization: Role of telomeres and telomerase

Carcinogenesis

Volumn 26, Issue 5, 2005, Pages 867-874

  Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL DIVISION; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOME BREAKAGE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE; AGING; CELL AGING; CELL TRANSFORMATION; ENZYMOLOGY; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY;

AGING; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 19844382620     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh296     Document Type: Review

References (144)

1. Vogelstein, B. and Kinzler, K.W. (1993) The multistep nature of cancer. Trends Genet., 9, 138-141.
2. Faragher, R.G.A. and Kipling, D. (1998) How might replicative senescence contribute to human ageing? BioEssays, 20, 985-991.
3. Kapahi, P., Boulton, M.E. and Kirkwood, T.B. (1999) Positive correlation between mammalian life span and cellular resistance to stress. Free Radic. Biol. Med., 26, 495-500.
4. Hayflick, L. (1980) Cell aging. In Eisdorfer, C. (ed.) Annual Review of Gerontology and Geriatrics. Springer Publishing Co., New York, Vol. 1, pp. 26-67.
5. Hayflick, L. and Moorhead, P.S. (1961) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 25, 585-621.
6. Campisi, J. (2001) Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol., 11, 27-31.
7. Rubin, H. (1997) Cell aging in vivo and in vitro. Mech. Ageing Dev., 98, 1-35.
8. Wright, W.E. and Shay, J.W. (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol., 27, 383-389.
9. Wright, W.E. and Shay, J.W. (2002) Historical claims and current interpretations of replicative aging. Nat. Biotechnol., 20, 682-688.
10. Shay, J.W. and Roninson, I.B. (2004) Hallmarks of senescence in carcinogenesis and cancer therapy Oncogene, 23, 2919-2933.
11. Campisi, J. (2003) Cancer and ageing: rival demons? Nat. Rev. Cancer, 3, 339-349.
12. Maser, R.S. and DePinho, R.A. (2002) Connecting chromosomes, crisis and cancer. Science, 297, 565-569.
13. Wong, K.K. and DePinho, R.A. (2003) Walking the telomere plank into cancer. J. Natl Cancer Inst., 95, 1184-1186.
14. Meeker, A.K. and De Marzo, A.M. (2004) Recent advances in telomere biology: implications for human cancer. Curr. Opin. Oncol., 16, 32-38.
15. Meeker, A.K., Hicks, J.L., Iacobuzio-Donahue, C.A., Montgomery, E.A., Westra, W.H., Chan, T.Y., Ronnett, B.M. and De Marzo, A.M. (2004) Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res., 10, 317-326.
16. Sharpless, N.E. and DePinho, R.A. (2004) Telomeres, stem cells, senescence and cancer. J. Clin. Invest., 113, 160-168.
17. Slagboom, P.E., Droog, S. and Boomsma, D.I. (1994) Genetic detemination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet., 55, 876-882.
18. Benetos, A., Okuda, K., Lajemi, M., Kimura, M., Thomas, F., Skurnick, J., Lobat, C., Bean, K. and Aviv, A. (2001) Telomere length as an indicator of biologic aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension, 37, 381-385.
19. Brouilette, S., Singh, R.K., Thompson, J.R., Goodall, A.H. and Samani, N.J. (2003) White cell telomere length and risk of premature myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 23, 842-846.
20. Okuda, K., Bardequez, A., Gardner, J.P., Rodriguez, P., Ganesh, V., Kimura, M., Skurnick, J., Awad, G. and Aviv, A. (2002) Telomere length in the newborn. Pediat. Res., 52, 377-381.
21. Graakjaer, J., Bischoff, C., Korsholm, L., Holstebroe, S., Vach, W., Bohr, V.A., Christensen, K. and Kolvraa, S. (2003) The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech. Ageing Dev., 124, 629-640.
22. Vulliamy, T., Marrone, A., Goldman, F. et al. (2001) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature, 413, 432-435.
23. Mitchell, J.R., Wood, E. and Collins, K. (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature, 402, 551-555.
24. Shay, J.W. and Wright, W.E. (1999) Mutant dyskerin ends relationship with telomerase. Science, 286, 2284-2285.
25. Wong, J.M. and Collins, K. (2003) Telomere maintenance and disease. Lancet, 362, 983-988.
26. Shay, J.W. and Wright, W. E. (2004) Telomeres in dyskeratosis congenita Nature Genet., 36, 437-438.
27. Cawthon, R.M., Smith, K.R., O'Brien, E., Sivatchenko, A. and Kerber, R.A. (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet, 361, 393-395.
28. Lindsey, J., McGill, N., Lindsey, L., Green, D. and Cooke, H. (1991) In vivo loss of telomeric repeats with age in humans. Mutat. Res., 256, 45-48.
29. Wu, X. Amos, C.I., Zhu, Y., Zhao, H., Grossman, B.H., Shay, J.W., Swan, G.E., Benowitz, N.L., Luo, S. and Spitz, M.R. (2003) Telomere dysfunction: a potential cancer predisposition factor. J. Natl. Cancer Inst., 95, 1211-1218.
30. Kitada, T., Seki, S., Kawakita, N., Kuroki, T. and Monna, T. (1995) Telomere shortening in chronic liver diseases. Biochem. Biophys. Res. Commun., 211, 33-39.
31. Wiemann, S.U., Satyanarayana, A., Tsahuridu, M. et al. (2002) Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J., 16, 935-942.
32. Samani, N.J., Boultby, R., Butler, R., Thompson, J.R. and Goodall, A.H. (2001) Telomere shortening in atherosclerosis. Lancet, 358, 472-473.
33. Obana, N., Takagi, S., Kinouchi, Y. et al. (2003) Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders. Intern. Med., 42, 150-153.
34. Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green, D.K. and Allshire, R.C. (1990) Telomere reduction in human colorectal carcinoma and with aging. Nature, 346, 866-868.
35. Chadeneau, C., Hay, K., Hirte, H.W., Gallinger, S. and Bacchetti, S. (1995) Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55, 2533-2536.
36. Engelhardt, M., Drullinsky, P., Guillem, J. and Moore, M.A. (1997) Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res., 3, 1931-1941.
37. Tang, R., Cheng, A.J., Wang, J.Y. and Wang, T.C. (1998) Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer Res., 58, 4052-4054.
38. Yan, P., Saraga, E.P., Bouzourene, H., Bosman, F.T. and Benhattar, J. (1999) Telomerase activation in colorectal carcinogenesis. J. Pathol., 189, 207-212.
39. Rudolph, K.L., Millard, M., Bosenberg, M.W. and DePinho, R.A. (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nature Genet., 28, 155-159.
40. Herrera, E., Samper, E., Martin-Caballero, J., Flores, J.M., Lee, H.W. and Blasco, M.A. (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J., 18, 2950-2960.
41. de Lange, T. (2004) T-loops and the origin of telomeres. Nature Rev. Mol. Cell Biol, 5, 323-329.
42. Allshire, R.C., Dempster, M. and Hastie, N.D. (1989) Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res., 17, 4611-4627.
43. Baird, D.M., Coleman J., Rosser, Z.H. and Royle, N.J. (2000) High levels of sequence polymorphism and linkage disequilibrium at the telomere of 12q: implications for telomere biology and human evolution. Am. J. Hum. Genet., 66, 235-250.
44. Baird, D.M., Rowson, J., Wynford-Thomas, D. and Kipling, D. (2003) Extensive allelic variation and ultrashort telomeres in senescent human cells. Nature Genet., 33, 203-207.
45. Blackburn, E.H. (2001) Switching and signaling at the telomere. Cell, 106, 661-673.
46. Blasco, M. (2004) Telomere epigenetics: a higher-order control of telomere length in mammalian cells. Carcinogenesis, 25, 1083-1087.
47. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A. and Greider, C.W. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25-34.
48. Blasco, M.A. (2003) Mammalian telomeres and telomerase: why they matter for cancer and aging. Eur. J. Cell Biol., 82, 441-446.
49. Broccoli, D., Smogorzewska, A., Chong, L. and de Lange, T. (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nature Genet., 17, 231-235.
50. Chan, S.R. and Blackburn, E.H. (2004) Telomeres and telomerase. Phil. Trans. Roy. Soc. London Ser. B Biol. Sci., 359, 109-121.
51. de Lange, T. (2002) Protection of mammalian telomeres. Oncogene, 21, 532-540.
52. der-Sarkissian, H., Bacchetti, S., Cazes, L. and Londono-Vallejo, J.A. (2004) The shortest telomeres drive karyotype evolution in transformed cells. Oncogene, 23, 1221-1228.
53. Ferreira, M.G., Miller, K.M. and Cooper, J.P. (2004) Indecent exposure: when telomeres become uncapped. Mol. Cell, 13, 7-18.
54. Goytisolo, F.A. and Blasco, M.A. (2002) Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene, 21, 584-591.
55. Griffith, J.D., Comeau, L., Rosenfield, S., Stansel, R.M., Bianchi, A., Moss, H. and de Lange, T. (1999) Mammalian telomeres end in a large duplex loop. Cell, 97, 503-514.
56. Greider, C.W. (1990) Telomeres, telomerase and senescence. Bioessays, 12, 363-369.
57. Greider, C.W. and Blackburn, E.H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43, 405-413.
58. Harley, C.B. (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat. Res., 256, 271-282.
59. Harley, C.B., Fletcher, A.B. and Greider, C.W. (1990) Telomeres shorten during aging. Nature, 345, 458-460.
60. Harrington, L. (2004) Those damaged telomeres! Curr. Opin. Genet. Dev., 14, 22-28.
61. Hemann, M.T., Strong, M.A., Hao, L.Y. and Greider, C.W. (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell, 107, 67-77.
62. Huffman, K.E., Levene, S.D., Tesmer, V.M., Shay, J.W. and Wright, W.E. (2000) Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang. J. Biol. Chem., 275, 19719-19722.
63. Keys, B., Serra, V., Saretzki, G. and von Zglinicki, T. (2004) Telomere shortening in human fibroblasts is not dependent on the size of the telomeric-3′-overhang. Aging Cell, 3, 103-109.
64. Levy, M.Z., Allsopp, R.C., Futcher, A.B., Greider, C.W. and Harley, C.B. (1992) Telomere end-replication problem and cell aging. J. Mol. Biol., 225, 951-960.
65. Londono-Vallejo, J.A., DerSarkissian, H., Cazes, L. and Thomas, G. (2001) Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res., 29, 3164-3171.
66. Martens, U.M., Chavez, E.A., Poon, S.S., Schmoor, C. and Lansdorp, P.M. (2000) Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp. Cell Res., 256, 291-299.
67. n, present at the telomeres of human chromosomes. Proc. Natl Acad. Sci. USA, 85, 6622-6626.
68. Olovnikov, A.M. (1973) A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theoret. Biol., 41, 181-190.
69. Stewart, S.A., Ben-Porath, I., Carey, V.J., O'Connor, B.F., Hahn, W.C. and Weinberg, R.A. (2003) Erosion of the telomeric single-strand overhang at replicative senescence. Nature Genet., 33, 492-496.
70. Suda, T., Fujiyama, A., Takimoto, M., Igarashi, M., Kuroiwa, T., Waguri, N., Kawai, H., Mita, Y. and Aoyagi, Y. (2002) Interchromosomal telomere length variation. Biochem. Biophys. Res. Commun., 291, 210-214.
71. van Steensel, B., Smogorzewska, A. and de Lange, T. (1998) TRF2 protects human telomeres from end-to-end fusions. Cell, 92, 401-413.
72. von Zglinicki, T. (2002) Oxidative stress shortens telomeres. Trends Biochem. Sci., 27, 339-344.
73. von Zglinicki, T., Saretzki, G., Docke, W. and Lotze, C. (1995) Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp. Cell Res., 220, 186-193.
74. Watson, J.D. (1972) Origin of concatameric T4 DNA. Nature, 239, 197-201.
75. Wright, W.E. and Shay, J.W. (2000) Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nature Med., 6, 849-851.
76. Wright, W.E. and Shay, J.W. (2003) Telomere shortening and replicative aging. In Hisama, F.M., Weissman, S.M. and Martin, G.M. (eds) Chromosomal instability and Aging: Basic Science and Clinical implication. Marcel Dekker, Inc., New York, pp. 51-72.
77. Smith, S., Giriat, I., Schmitt, A. and de Lange, T. (1998) Tankyrase, a poly (ADP-ribose) polymerase at human telomeres. Science, 282, 1484-1487.
78. Blackburn, E.H. (1992) Telomerases. Ann. Rev. Biochem., 61, 113-129.
79. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chui, C.-P., Morin, G.B., Harley, C.B., Shay, J.W., Lichsteiner, S. and Wright, W.E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-352.
80. Bryan, T.M. and Cech, T.R. (1999) Telomerase and the maintenance of chromosome ends. Curr. Opin. Cell. Biol., 11, 318-324.
81. Chan, S.W.-L. and Blackburn, E.H. (2002) New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene, 21, 553-563.
82. Coursen, J.D., Bennett, W.P., Gollahon, L., Shay, J.W. and Harris, C.C. (1997) Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes. Exp. Cell Res., 235, 245-253.
83. Feng, J., Funk, W.D. and Wang, S.-S. et al. (1995) The RNA component of human telomerase. Science, 269, 1236-1241.
84. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W. and Weinberg, R.A. (1999) Creation of human tumour cells with defined genetic elements. Nature, 499, 464-468.
85. Holt, S.E. and Shay, J.W. (1999) The role of telomerase in cellular proliferation and cancer. J. Cell Physiol., 180, 10-18.
86. Holt, S.E., Wright, W.E. and Shay, J.W. (1996) Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol., 16, 1932-1939.
87. Jiang, X.R., Jimenez, G., Chang, E. et al. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet., 21, 111-114.
88. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
89. Lingner, J., Cooper, J.P. and Cech, T.R. (1995) Telomerase and DNA end replication: no longer a lagging strand problem? Science, 269, 1533-1534.
90. Masutomi, K., Yu, E.Y., Khurts, S. et al. (2003) Telomerase maintains telomere structure in normal human cells. Cell, 114, 241-253.
91. Morales, C.P., Holt, S.E., Ouellette, M., Kaur, K.J., Yan, Y., Wilson, K.S., White, M.A., Wright, W.E. and Shay, J.W. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet., 2, 115-118.
92. Ouellette, M.M., McDaniel, L.D., Wright, W.E., Shay, J.W. and Schultz, R.A. (2000) The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum. Mol. Genet., 9, 403-411.
93. Ouellette, M.M., Liao, M., Herbert, B.S., Johnson, M., Holt, S.E., Liss, H.S., Shay, J.W. and Wright, W.E. (2000) Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J. Biol. Chem., 275, 10072-10076.
94. Shay, J.W. (1998) Telomerase in cancer: diagnostic, prognostic and therapeutic implications. Cancer J. Sci. Am., 4 (suppl. 1), S26-S34.
95. Shay, J.W. (1999) Toward identifying a cellular determinant of telomerase repression. J. Natl Cancer Inst., 91, 4-6.
96. Shay, J.W. and Wright, W.E. (2000) The use of telomerized cells for tissue engineering. Nat. Biotechnol. 18, 22-23.
97. Shay, J.W. and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer, 33, 787-791.
98. Shay, J.W. and Wright, W.E. (2002) Telomerase: a target for cancer therapeutics. Cancer Cell, 2, 257-265.
99. Shay, J.W. (2003) Telomerase therapeutics: telomeres recognized as a DNA damage signal. Clin. Can. Res., 9, 3521-3525.
100. Granger, M.P., Wright, W.E. and Shay, J.W. (2002) Telomerase in cancer and aging. Crit. Rev. Oncol. Hematol., 41, 29-40.
101. Steinert, S., Shay, J.W. and Wright, W.E. (2000) Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem. Biophys. Res. Commun., 273, 1095-1098.
102. Vaziri, H. and Benchimol, S. (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol., 8, 279-282.
103. Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W. and Shay, J.W. (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet., 18, 173-179.
104. Wright, W.E., Brasiskyte, D., Piatyszek, M.A. and Shay, J.W. (1996) Experimental elongation of telomeres in immortal human cells extends the lifespan of immortal×normal cell hybrids. EMBO J., 15, 1734-1741.
105. Wyllie, F.S., Jones, C.J., Skinner, J.W., Haughton, M.F., Wallis, C., Wynford-Thomas, D., Faragher, R.G. and Kipling, D. (2000) Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nature Genet., 24, 16-17.
106. Yang, J., Chang, E., Cherry, A.M., Bangs, C.D., Oei, Y., Bodnar, A., Bronstein, A., Chiu, C.P. and Herron, G.S. (1999) Human endothelial cell life extension by telomerase expression. J. Biol. Chem., 274, 26141-26148.
107. Bryan, T.M., Marusic, L., Bacchetti, S., Namba, M. and Reddel, R.R. (1997) The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet., 6, 921-926.
108. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R.R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J., 14, 4240-4248.
109. Dunham, M.A., Neumann, A.A., Fasching, C.L. and Reddel, R.R. (2000) Telomere maintenance by recombination in human cells. Nature Genet., 26, 447-450.
110. Reddel, R.R. (2003) Alternative lengthening of telomeres, telomerase and cancer. Cancer Lett., 194, 155-162.
111. Ford, L.P., Zou, Y., Pongracz, K., Gryaznov, S.M., Shay, J.W. and Wright, W.E. (2001) Telomere maintenance by telomerase can inhibit the ALT pathway in human cells. J. Biol. Chem., 276, 32198-32203.
112. Bechter, O.E., Shay, J.W. and Wright, W.E. (2004) The frequency of homologous recombination in human ALT cells. Cell Cycle, 5, 49-51.
113. Bechter, O., Zou, Y., Walker, W., Wright, W.E. and Shay, J.W. (2004) Telomeric recombination in MSH6 deficient human colon cancer cells following telomerase inhibition Cancer Res., 64, 3444-3451.
114. Bechter, O.E., Zou, Y., Shay, J.W. and Wright, W.E. (2003) Homologous recombination in human telomerase positive and ALT cells occurs with the same frequency. EMBO Rep., 4, 1138-1143.
115. Aisner, D.L., Wright, W.E. and Shay, J.W. (2002) Telomerase regulation: not just flipping the switch Curr. Opin. Genet. Dev., 12, 80-85.
116. Forsyth, N.R., Wright, W.E. and Shay, J.W. (2002) Telomerase and differentiation in multicellular organisms: turn it off, turn it on and turn it off again. Differentiation, 69, 188-197.
117. Ramirez, R.D., Morales, C.P., Herbert, B.S., Rohde, J.M., Passons, C., Shay, J.W. and Wright, W.E. (2001) Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev., 15, 398-403.
118. Robles, S.J. and Adami, G.R. (1998) Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene, 16, 1113-1123.
119. Serrano, M. and Blasco, M. (2001) Putting the stress on senescence. Curr. Opin. Cell Biol., 13, 748-753.
120. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. and Lowe, S.W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88, 593-602.
121. Sherr, C.J. and DePinho, R.A. (2000) Cellular senescence: mitotic clock or culture shock? Cell, 102, 407-410.
122. Zhu, J., Woods, D., McMahon, M. and Bishop, J.M. (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev., 12, 2997-3007.
123. Drayton, S. and Peters, G. (2002) Immortalisation and transformation revisited. Curr. Opin. Genet. Dev., 12, 98-104.
124. Jones, C.J., Kipling, D., Morris, M. et al. (2000) Evidence for a telomere-independent 'clock' limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol. Cell Biol., 20, 5690-5699.
125. Dickson, M.A., Hahn, W.C., Ino, Y., Ronfard, V., Wu, J.Y., Weinberg, R.A., Louis, D.N., Li, F.P. and Rheinwald, J.G. (2000) Human keratinocytes that express hTERT and also bypass a p16 (INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol., 20, 1436-1447.
126. Farwell, D.G., Shera, K.A., Koop, J.I., Bonnet, G.A., Matthews, C.P., Reuther, G.W., Coltrera, M.D., McDougall, J.K. and Klingelhutz, A.J. (2000) Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am. J. Pathol., 156, 1537-1547.
127. Forsyth, N.R., Evans, A.P., Shay, J.W. and Wright, W.E. (2003) Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell, 2, 235-243.
128. Jarrard, D.F., Sarkar, S., Shi, Y. et al. (1999) p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res., 592, 957-964.
129. Kiyono, T., Foster, S.A., Koop, J.I., McDougall, J.K., Galloway, D.A. and Klingelhutz, A.J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells [see comments]. Nature, 396, 84-88.
130. Ramirez, R.D., Herbert, B.-S., Vaughn, M.B., Zou, Y., Gandia, K., Morales, C.P., Wright, W.E. and Shay, J.W. (2003) Bypass of telomere-dependent replicative senescence (M1) upon over expression of CDK4 in normal human epithelial Oncogene, 2, 433-444.
131. Dimri, G.P., Lee, X., Basile, G. et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA, 92, 9363-9367.
132. Busutil, R.A., Rubio, M., Dolle, M.E.T., Campisi, J. and Vijg, J. (2003) Oxygen accelerates the accumulation of mutations during senescence and immortalization of murine cells in culture. Aging Cell, 2, 287-294.
133. Naka, K., Tachibana, A., Ikeda, K. and Motoyama, N. (2004) Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J. Biol. Chem., 279, 2030-2037.
134. Baur, J.A., Zou, Y., Shay, J.W. and Wright, W.E. (2001) Telomere position effect in human cells. Science, 292, 2075-2077.
135. Koering, C.E., Pollice, A., Zibella, M.P. et al. (2002) Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity. EMBO Rep., 3, 1055-1061.
136. Shay, J.W. and Wright, W.E. (2000) Implications of mapping the human telomerase genes (hTERT) as the most distal gene on chromosome 5p. Neoplasia, 2, 195-196.
137. d'Adda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N.P. and Jackson, S.P. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature, 426, 194-198.
138. Zou, Y., Sfeir, A., Shay, J.W. and Wright, W.E. (2004) Groups of short telomeres determine replicative senescence. Mol. Biol. Cell, 15, 3709-3718.
139. Sedelnikova, O.A., Horikawa, I., Zimonjic, D.B., Popescu, N.C., Bonner, W.M. and Barrett, J.C. (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell Biol., 6, 168-170.
140. Gire, V., Roux, P., Wynford-Thomas, D., Brondello, J.M. and Dulic, V. (2004) DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J., 7, 2554-2563.
141. Herbig, U., Jobling, W.A., Chen, P.B.C., Chen, D.J. and Sedivy, J.M. (2004) Telomere shortening triggers senescence of human cells through a signaling pathway involving ATM, p53 and p21CIP1 but not p16INK4a. Mol. Cell, 13, 501-513.
142. Takai, H., Smogorzewska, A. and de Lange, T. (2003) DNA damage foci at dysfunctional telomeres. Curr. Biol., 13, 1549-1556.
143. Shay, J.W. and Wright, W.E. (2004) Are telomeres double-strand DNA breaks that are hidden from DNA damage responses? Mol. Cell, 14, 420-421.
144. O'Sullivan, J.N., Bronner, M.P., Brentnall, T.A. et al. (2002) Chromosomal instability in ulcerative colitis is related to telomere shortening. Nature Genet., 32, 280-284.